These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38113996)

  • 1. Association between comorbid chronic pain or prior hospitalization for mental illness and substance use treatment among a cohort at high risk of opioid overdose.
    Rosenfield MN; Beaudoin FL; Gaither R; Hallowell BD; Daly MM; Marshall BDL; Chambers LC
    J Subst Use Addict Treat; 2024 Apr; 159():209273. PubMed ID: 38113996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit.
    Weiner SG; Little K; Yoo J; Flores DP; Hildebran C; Wright DA; Ritter GA; El Ibrahimi S
    JAMA Netw Open; 2024 Jul; 7(7):e2423954. PubMed ID: 39037812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial.
    Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL
    JAMA Netw Open; 2022 Aug; 5(8):e2225582. PubMed ID: 35943744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.
    John WS; Wu LT
    Drug Alcohol Depend; 2020 Apr; 209():107902. PubMed ID: 32088587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17.
    Larney S; Jones NR; Hickman M; Nielsen S; Ali R; Degenhardt L
    Addiction; 2023 Aug; 118(8):1527-1539. PubMed ID: 36843415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telehealth Initiation of Buprenorphine for Opioid Use Disorder: Patient Characteristics and Outcomes.
    Nguyen B; Zhao C; Bailly E; Chi W
    J Gen Intern Med; 2024 Jan; 39(1):95-102. PubMed ID: 37670069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder.
    Naeger S; Mutter R; Ali MM; Mark T; Hughey L
    J Subst Abuse Treat; 2016 Oct; 69():64-71. PubMed ID: 27568512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone Initiation in the Emergency Department for Opioid Use Disorder.
    Wolfson D; King R; Lamberson M; Lyttleton J; Waters CT; Schneider SH; Porter BA; DeWitt KM; Jackson P; Stevens MW; Brooklyn J; Rawson R; Riser E
    West J Emerg Med; 2024 Sep; 25(5):668-674. PubMed ID: 39319796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study.
    Macmadu A; Paull K; Youssef R; Batthala S; Wilson KH; Samuels EA; Yedinak JL; Marshall BDL
    Drug Alcohol Depend; 2021 Feb; 219():108435. PubMed ID: 33310383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Current Opioid Use With Serious Adverse Events Among Older Adult Survivors of Breast Cancer.
    Winn AN; Check DK; Farkas A; Fergestrom NM; Neuner JM; Roberts AW
    JAMA Netw Open; 2020 Sep; 3(9):e2016858. PubMed ID: 32930779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiation.
    Sun T; Aroke H; Kogut S; Katenka N; Bratberg J; Buchanan A
    Am J Drug Alcohol Abuse; 2022 Mar; 48(2):217-225. PubMed ID: 34780312
    [No Abstract]   [Full Text] [Related]  

  • 13. Mental Health Distress Is Associated With Higher Pain Interference in Patients With Opioid Use Disorder Stabilized on Buprenorphine or Methadone.
    Leyde S; Price CJ; Colgan DD; Pike KC; Tsui JI; Merrill JO
    Subst Use Addctn J; 2024 Jul; 45(3):423-433. PubMed ID: 38327009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of buprenorphine retention and subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases.
    Sugarman OK; Saloner B; Richards TM; Lasser EC; Heath T; Idries S; Weiner JP; Bandara S
    Drug Alcohol Depend; 2024 May; 258():111281. PubMed ID: 38599134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
    Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
    Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Emergency Department-Initiated Buprenorphine on Repeat Emergency Department Utilization.
    Skains RM; Reynolds L; Carlisle N; Heath S; Covington W; Hornbuckle K; Walter L
    West J Emerg Med; 2023 Nov; 24(6):1010-1017. PubMed ID: 38165181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings.
    Presnall NJ; Wolf DAPS; Brown DS; Beeler-Stinn S; Grucza RA
    J Subst Abuse Treat; 2019 Sep; 104():135-143. PubMed ID: 31370977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit.
    Taylor JL; Gott J; Weisenthal K; Colicchio P; Dyer S; Komaromy MS
    Subst Use Addctn J; 2024 Oct; 45(4):771-776. PubMed ID: 38736211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage.
    Dennis BB; Babe G; Gayowsky A; Rosic T; Rodrigues M; Bach P; Perez R; de Oliveira C; Samet J; Weaver V; Young S; Dionne J; Ahmed A; Kim D; Thabane L; Samaan Z
    J Subst Use Addict Treat; 2024 Dec; 167():209524. PubMed ID: 39341602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.